SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0001558370-21-006524
Filing Date
2021-05-07
Accepted
2021-05-07 17:00:25
Documents
9
Period of Report
2021-07-16

Document Format Files

Seq Description Document Type Size
1 PRE 14A tmb-20210716xpre14a.htm PRE 14A 873102
2 GRAPHIC tmb-20210716xpre14a017.jpg GRAPHIC 100038
3 GRAPHIC tmb-20210716xpre14a019.jpg GRAPHIC 122901
4 GRAPHIC tmb-20210716xpre14a018.jpg GRAPHIC 118188
5 GRAPHIC tmb-20210716xpre14a002.jpg GRAPHIC 4283
6 GRAPHIC tmb-20210716xpre14a016.jpg GRAPHIC 137181
7 GRAPHIC tmb-20210716xpre14a015.jpg GRAPHIC 105859
8 GRAPHIC tmb-20210716xpre14a001.jpg GRAPHIC 4398
9 GRAPHIC tmb-20210716xpre14a014.jpg GRAPHIC 141141
  Complete submission text file 0001558370-21-006524.txt   1886207
Mailing Address ONE KENDALL SQUARE BUILDING 1400 EAST 4TH FLOOR CAMBRIDGE MA 02139
Business Address ONE KENDALL SQUARE BUILDING 1400 EAST 4TH FLOOR CAMBRIDGE MA 02139 617-863-5524
INVIVO THERAPEUTICS HOLDINGS CORP. (Filer) CIK: 0001292519 (see all company filings)

IRS No.: 000000000 | State of Incorp.: NV | Fiscal Year End: 1231
Type: PRE 14A | Act: 34 | File No.: 001-37350 | Film No.: 21903735
SIC: 3841 Surgical & Medical Instruments & Apparatus